NO20004312D0 - FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer - Google Patents

FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer

Info

Publication number
NO20004312D0
NO20004312D0 NO20004312A NO20004312A NO20004312D0 NO 20004312 D0 NO20004312 D0 NO 20004312D0 NO 20004312 A NO20004312 A NO 20004312A NO 20004312 A NO20004312 A NO 20004312A NO 20004312 D0 NO20004312 D0 NO 20004312D0
Authority
NO
Norway
Prior art keywords
preparation
heterocyclic ring
ring systems
lipoxygenase inhibitors
various heterocyclic
Prior art date
Application number
NO20004312A
Other languages
English (en)
Other versions
NO20004312L (no
Inventor
Timothy Norris
Megan Elizabeth Hnatow
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20004312D0 publication Critical patent/NO20004312D0/no
Publication of NO20004312L publication Critical patent/NO20004312L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20004312A 1999-08-31 2000-08-30 Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer NO20004312L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15161099P 1999-08-31 1999-08-31

Publications (2)

Publication Number Publication Date
NO20004312D0 true NO20004312D0 (no) 2000-08-30
NO20004312L NO20004312L (no) 2001-03-01

Family

ID=22539510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004312A NO20004312L (no) 1999-08-31 2000-08-30 Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer

Country Status (33)

Country Link
EP (1) EP1081144A3 (no)
JP (1) JP2001106686A (no)
KR (1) KR20010050274A (no)
CN (1) CN1286251A (no)
AP (1) AP2000001909A0 (no)
AR (1) AR022650A1 (no)
AU (1) AU5370200A (no)
BG (1) BG104730A (no)
BR (1) BR0003888A (no)
CA (1) CA2316748A1 (no)
CO (1) CO5180623A1 (no)
CZ (1) CZ20003159A3 (no)
EA (1) EA200000803A3 (no)
EE (1) EE200000513A (no)
GT (1) GT200000144A (no)
HR (1) HRP20000565A2 (no)
HU (1) HUP0003437A3 (no)
ID (1) ID27128A (no)
IL (1) IL138089A0 (no)
IS (1) IS5604A (no)
MA (1) MA26750A1 (no)
NO (1) NO20004312L (no)
NZ (1) NZ506633A (no)
OA (1) OA11451A (no)
PA (1) PA8499601A1 (no)
PE (1) PE20010523A1 (no)
PL (1) PL342280A1 (no)
SG (1) SG87145A1 (no)
SK (1) SK12862000A3 (no)
SV (1) SV2002000160A (no)
TN (1) TNSN00176A1 (no)
TR (1) TR200002530A2 (no)
UY (1) UY26315A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060188557A1 (en) * 2003-05-23 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor
US7674811B2 (en) 2006-03-14 2010-03-09 Ranbaxy Laboratories Limited 5-lipoxygenase inhibitors
CN103980312B (zh) * 2014-05-27 2016-09-07 广州大学 一种n杂环双膦配体及其合成方法
WO2025038927A1 (en) * 2023-08-16 2025-02-20 Raythera, Inc. Modulators of tnf alpha activity and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze

Also Published As

Publication number Publication date
EE200000513A (et) 2001-04-16
CZ20003159A3 (cs) 2001-12-12
HUP0003437A3 (en) 2002-08-28
EP1081144A3 (en) 2001-04-11
OA11451A (en) 2003-12-08
SG87145A1 (en) 2002-03-19
CA2316748A1 (en) 2001-02-28
HUP0003437A2 (hu) 2001-06-28
IS5604A (is) 2001-03-01
SK12862000A3 (sk) 2002-02-05
MA26750A1 (fr) 2004-12-20
PE20010523A1 (es) 2001-04-28
NO20004312L (no) 2001-03-01
KR20010050274A (ko) 2001-06-15
SV2002000160A (es) 2002-01-23
JP2001106686A (ja) 2001-04-17
IL138089A0 (en) 2001-10-31
UY26315A1 (es) 2001-04-30
BR0003888A (pt) 2001-12-11
EA200000803A3 (ru) 2001-06-25
TR200002530A2 (tr) 2001-04-20
HRP20000565A2 (en) 2001-06-30
EA200000803A2 (ru) 2001-04-23
NZ506633A (en) 2001-12-21
TNSN00176A1 (fr) 2005-11-10
AR022650A1 (es) 2002-09-04
AU5370200A (en) 2001-03-08
ID27128A (id) 2001-03-01
PA8499601A1 (es) 2002-02-21
CN1286251A (zh) 2001-03-07
HU0003437D0 (en) 2000-08-30
GT200000144A (es) 2002-02-20
EP1081144A2 (en) 2001-03-07
AP2000001909A0 (en) 2000-09-30
PL342280A1 (en) 2001-03-12
CO5180623A1 (es) 2002-07-30
BG104730A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
NO20022510L (no) Fremgangsmåte for sammenkopling av rör
NO20022864L (no) Aminotiazol inhibitorer av syklin uavhengig kinase
NO20014535L (no) Inhibitorer av IMPDH-enzym
NO20100667L (no) Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater
NO20015547L (no) Fremgangsmåte for hemisyntese av forbindelser og nye forbindelser
NO20022125D0 (no) Pyrrolderivater som inhibitorer for fosfodiesterase VII
NO20024256D0 (no) Fremgangsmåte for fremstilling av pyrimidonderivater med antifungal aktivitet
NO20022123D0 (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO20004312D0 (no) FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med forskjellige heterocycliske ringsystemer
NO20020059L (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20004313D0 (no) FremgangsmÕte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer
NO20013407D0 (no) Fremgangsmåte for fremstilling av kinolinkarbaldehyd
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20013995D0 (no) Fremgangsmate for fremstilling av L-sorbose
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20020073D0 (no) Fremgangsmåte ved fremstilling av trisykliske aminoalkoholderivater
IL138088A0 (en) Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
NO20032297D0 (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20022157D0 (no) Fremgangsmåte for behandling av medikamentavhengighet
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
DK1041070T3 (da) Fremgangsmåde til fremstilling af cykliske thioamider
NO20014451D0 (no) Fremgangsmåte for fremstilling av tiazolidinderivater
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20022671D0 (no) Fremgangsmåte for fremstilling av tienopyrimidiner
NO993313L (no) Derivater av 5-nitrofurfural

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application